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LOW DOSES OF RADIATION REDUCE RISK IN VIVO
R. E. J. Mitchel  Radiation Biology and Health Physics Branch, AECL, Chalk
River Laboratories, Chalk River, ON, Canada
 The “Linear No Threshold” hypothesis, used in all radiation protection practices,
assumes that all doses, no matter how low, increase the risk of cancer, birth defects and
heritable mutations. In vitro cell based experiments show adaptive processes in response
to low doses and dose rates of low LET radiation, and do not support the hypothesis. This
talk will present cellular data and data from animal experiments that test the hypothesis
in vivo for cancer risk. The data show that a single, low, whole body dose (less than about
100 mGy) of low LET radiation, given at low dose rate, increased cancer latency and con-
sequently reduced both spontaneous and radiation-induced cancer risk in both genetical-
ly normal and cancer-prone mice. This adaptive response lasted for the entire lifespan of
all the animals that developed these tumors, and effectively restored a portion of the life
that would have been lost due to the cancer in the absence of the low dose. Overall, the
results demonstrate that the assumption of a linear increase in risk with increasing dose in
vivo is not warranted, and that low doses actually reduce risk.
I. INTRODUCTION
All current radiation risk estimates and all radiation-protection stan-
dards and practices are based on the so-called “Linear No-Threshold
Hypothesis”. This LNT hypothesis is in turn, based mainly on epidemio-
logical data of humans exposed to high doses and dose rates but is con-
sidered to also apply at low doses and dose rates, with a two-fold reduc-
tion in risk. The hypothesis states that:
1. Risk per unit dose is constant without a threshold.
2. Risk is additive.
3. Biological variables are insignificant compared to dose.
These assumptions allow radiation dose to be used as a surrogate for
radiation risk. However, at low doses the LNT hypothesis is acknowledged
to be an assumption, and other dose responses are also possible, includ-
ing supralinear, sublinear or threshold/hormetic responses. This paper
presents data testing the validity of low dose risk estimates that are based
on the LNT hypothesis, and will focus on cancer risk, considered to be
the most important measure of risk. However, other papers presented at
this meeting will focus on teratogenic effects and heritable mutations,
also important measures of risk. 
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While ultimately the influence of low doses on the risk of carcino-
genesis must be measured in vivo, it is important to understand the mech-
anisms underlying any such effects. Experiments conducted in other
organisms, or based on human and other cells grown in issue culture can
provide such information. Therefore, in addition to in vivo data, this
paper also presents the results of cellular experiments that indicate the
mechanisms that may be involved.
If we consider the potential biological consequences of a radiation
exposure to a normal cell, there are three general biological outcomes of
DNA damage1 as shown in Figure 1. When DNA damage is created as a
result of one or more tracks of radiation through a normal cell, the cell
will attempt to repair that damage. If the repair is successful and the DNA
restored to its original state, i.e., an error-free repair, then the cell is also
restored to normal. In this case, there is no resulting consequence to the
cell and hence no resulting risk. Another possibility is that the cell rec-
ognizes that it cannot properly repair the damage, and as a consequence
activates its genetically encoded cell death process, called apoptosis.
Again, in this case, no risk of carcinogenesis results since dead cells do
not produce cancer. The third possible outcome of the DNA damage is
repair that avoids cell death but which is error-prone, resulting in a mis-
take that creates a mutation. At this point, the cell may still activate its
apoptotic cell death program but could also simply resume dividing.
Creation of these errors is part of a process called genomic instability,
which can ultimately lead to cancer. Of the three possible outcomes,
therefore, only one creates a risk of carcinogenesis. It is useful to remem-
ber that the LNT hypothesis implies that risk is influenced only by dose,
and hence predicts that the relative proportions of these three biological
possibilities must be constant. If they were not constant, then risk would
vary with their relative proportions, and not strictly as a function of dose.
R. E. J. Mitchel
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FIGURE 1. Possible outcomes of a cellular radiation exposure in a normal cell
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II. EXPERIMENTAL RESULTS AND DISCUSSION
Cellular Studies
A common result of a radiation exposure in cells, particularly a high
dose exposure, is a break in one or more chromosomes, which indicate
DNA double strand breaks. If cells divide before repairing those breaks,
the remaining pieces of chromosomes are packaged into micronuclei
(MN). Measuring the frequency of MN in cells that have been exposed
and allowed to repair therefore represents a measure of the competence
of the cells at repairing such chromosomal breaks (and therefore DNA
double strand breaks) in response to radiation damage. We have tested the
influence of low doses and low dose rate exposures on the ability of human
skin cells to repair radiation breaks in chromosomes2. Figure 2 shows the
MN frequency in cells exposed to a variety of doses (1-500 mGy) delivered
at a low dose rate (3 mGy/min) 3h before exposure to a high dose (4 Gy)
delivered at a high dose rate (1.8 Gy/min). The LNT hypothesis predicts
that the consequences of the two doses would be additive and yet the
experiment shows that they are not. The combined exposure resulted in
fewer broken chromosomes than the single acute 4 Gy exposure alone.
The figure also shows that enhanced repair occurs after 1 mGy, the lowest
γ dose possible in a single cell since it represents, on average, a single track
per cell. The figure also shows that higher doses, representing multiple
Low doses of radiation reduce risk in vivo
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FIGURE 2. Low doses enhance the repair of broken chromosomes in human cells. 
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tracks/cell, produce the same result as one track/cell when those tracks
from the higher doses are spaced out in time (3 mGy/min). This type of
analysis can be applied to in vivo situations that have particular impor-
tance in the environmental assessment and licensing of nuclear installa-
tions. For example we have shown3 that this adaptive response also occurs
in fibroblasts taken from wild white tailed deer, and therefore the conse-
quences of radioactive contamination in the environment may not be as
predicted by the conventional LNT assumptions.
A direct test of this idea is shown in Figure 3, which gives some pre-
liminary data4 obtained from leopard frogs living in either a radiologi-
cally clean pond or in a pond contaminated with tritium and 14C that gave
an annual dose of about 1 mGy. Liver cells from the frogs living in the
clean pond showed a normal adaptive response to low doses, as was seen
in the human cells in Figure 2. However, exposure of the frogs from the
contaminated pond to a large dose produced comparatively little increase
in chromosomal breakage in their liver cells, and this was only slightly
reduced if the frogs were given a prior low adapting dose.
This lack of chromosomal damage after a high dose indicates that the
frogs were already adapted to radiation by their environmental exposure.
This in vivo measure of the consequences of environmental radiation
exposure indicates that low levels of radioactivity in the environment may
not be harmful to organisms, and may only serve to enhance cellular
defence mechanisms. Evidence that improvement of cellular defence
mechanisms after low dose exposures is actually reducing cancer risk is
R. E. J. Mitchel
4
FIGURE 3. Repair of chromosome breaks in liver cells taken from frogs living in an uncontaminat-
ed pond (open bars) or a pond contaminated with 3H and 14C (shaded bars) delivering about 1
mGy/y to the frogs. 1. No further radiation exposure. 2. Frogs receiving 1-100 mGy of 60Co gamma
radiation at low dose rate. 3. Frogs receiving 4 Gy of 60Co gamma radiation at high dose rate. 4. Frogs
receiving 1-100 mGy at low dose rate 3h before 4 Gy at high dose rate.
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shown in Tables 1 and 2. Table 1 shows the results of an experiment5
using rodent cells and examining the influence of a prior low dose, given
at low dose rate, on the risk of malignant transformation resulting from a
subsequent high radiation dose. The risk associated with the high radia-
tion dose was reduced by a factor of 2-3 by the prior low dose, a result that
parallels the evidence for improved repair of radiation damage shown in
Figure. 2. 
The ability of a low dose to reduce the risk of a subsequent high dose
has importance for medical types of exposures, such as those used in can-
cer therapy, and for estimates of environmental impact for the nuclear
industry. However, the effect of the low dose alone is of more importance
for human exposures in the nuclear industry. Table 2 shows the experi-
ment testing the effects of low doses alone on malignant transformation
in rodent cells6. All the doses tested, between 1 and 100 mGy, given at low
dose rate, reduced the risk of spontaneous malignant transformation,
and all doses were equally effective. The lowest dose tested, 1 mGy of 60Co
γ radiation, represents an average of 1 ionization track per cell, the low-
est dose physically possible in one cell. Since radiation tracks are random,
not all cells actually receive one track, but all respond to the same extent
as they did when they certainly received one or more tracks at the higher
doses. This is evidence therefore, that not all cells are actually required to
be exposed (hit) by radiation in order to enhance their defences and
reduce their risk. Such distributed effects are known as bystander effects
and result from inter-cell signalling.
Cancer Risk in Animals
While experiments in cells provide important supporting information
about the actual molecular and cellular responses to low doses, ultimate-
Low doses of radiation reduce risk in vivo
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TABLE 1.
Treatment Transformation Frequency (× 10–4)
Control 3.7
4 Gy (high dose rate) 41
100 mGy (low dose rate) + 24h + 4 Gy (high dose rate) 16
TABLE 2.
Treatment Transformation Frequency (× 10–3)
Control 1.8
1 mGy 0.53
10 mGy 0.42
100 mGy 0.53
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ly experiments testing the effect of low doses on measures of risk such as
cancer must be conducted in whole mammals. Figure 4 show a test7 of the
influence of a low dose exposure on radiation-induced myeloid leukemia
in genetically normal mice. The figure shows that exposure to a high dose
of 1 Gy induces myeloid leukemia in mice, and as a result, those mice with
the disease lose a substantial portion of their normal lifespan. However,
increasing the total exposure, by exposing the mice to 100 mGy, at low
dose rate, the day before the 1 Gy exposure delayed the onset of those
cancers (P<10-3), effectively restoring a portion of the lifespan that would
otherwise have been lost in those mice that developed the disease. It is
important to note that the low “adapting” exposure did not affect the fre-
quency of the disease induced by the high radiation dose, only the laten-
cy. The carcinogenic process is thought to involve an initiating event,
which subsequently triggers an accelerating process of genomic instabili-
ty leading to multiple genomic rearrangements, ultimately producing a
cancer cell. The frequency of cancer is thought to reflect the number of
initiating events while the latency of the disease reflects the rate at which
the genomic instability process proceeds. The results shown in Figure 4
indicate that low doses delivered at low dose rates slows the rate of pro-
gression of the genomic instability process but does not change the fre-
quency of the cancer initiating events7.
Radiation protection standards and practices applied to humans must
consider the possibility that some individuals may be radiation-sensitive
and cancer-prone for genetic reasons. This raises the possibility that low
doses may produce effects in such individuals that are different, and
potentially more harmful, than those seen in genetically normal individu-
R. E. J. Mitchel
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FIGURE 4. Delayed appearance (P < 0.001) of radiation-induced myeloid leukemia (ML) in genetical-
ly normal mice by exposure to 100 mGy at low dose rate 24h before the carcinogenic 1 Gy exposure. 
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als. Figure 5 shows a test8 of this “worst case scenario”. Mice that are het-
erozygous for the p53 gene (Trp53 +/-) are compromised in their ability
to repair DNA damage and in their ability to initiate cell death in improp-
erly repaired cells (Figure 1). Consequently, such mice are both cancer
prone and radiation sensitive. Figure 5 shows that these mice sponta-
neously develop lymphomas, and a high 4 Gy dose of radiation increases
the frequency and dramatically accelerates the appearance of these
tumours. A dose of 10 mGy, given at a low dose rate the day before the 4
Gy exposure, delayed the onset of these lymphomas (P<10-4), but did not
significantly change the frequency. Correcting for competing causes of
death did not change this conclusion. This effect of increasing latency was
also seen in the genetically normal mice in Figure 4. Increasing the low
adapting dose to 100 mGy caused this protective effect to disappear. While
not increasing harm, 100 mGy apparently represents an upper threshold
for doses that are protective against radiation-induced lymphomas. 
Experiments testing the in vivo effect of low doses on cancer risk pro-
duced by high dose exposure are important for improving our under-
standing of the dominant biological outcome of such exposures, and are
potentially useful concepts for medical radiotherapy procedures.
However, for radiation protection standards and practices in the nuclear
industry, it is more important to understand the influence of low doses
on spontaneous cancer risk. Figure 6 shows the results of such a test9 in
Low doses of radiation reduce risk in vivo
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FIGURE 5. Appearance of lymphomas in unexposed cancer prone mice (Trp53 +/-) and in mice
exposed to 4 Gy with or without a prior low dose and dose rate exposure.
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the cancer prone p53 heterozygous mice that represent the “worst case
scenario”. The figure shows that unexposed, genetically normal mice
(Trp53 +/+) of this strain also spontaneously develop lymphomas but that
these cancers appear much earlier in the unexposed, cancer prone
(Trp53 +/-) mice. Exposure to an acute 4 Gy dose of radiation dramati-
cally accelerated this appearance. The figure also shows that a single
exposure of either 10 or 100 mGy, given at low dose rate to young mice,
restores a portion of the lifespan lost due to the disease in the unexposed,
cancer-prone mice (P<10-4). Unlike the result in Figure 5, where the lym-
phomas developed in mice that had subsequently received a high dose,
the protective effect against these spontaneously appearing cancers was
not lost when the dose was increased to 100 mGy. This result suggests that
the upper dose threshold for protective effects varies with the severity or
nature of the cancer-inducing event, with the threshold being higher for
less severe inducing events such as spontaneous occurrences. 
Other tumours also appear spontaneously in these cancer-prone
mice. Osteosarcomas develop in the spine and grow to the point where
they create paralysis in the mice. Figure 7 shows the time that these spon-
taneous cancers create paralysis in the mice, with and without a single
exposure to 10 mGy given at low dose rate when the mice were 8 weeks
old8. Compared to the mice not receiving the low dose, the appearance
of the first spinal osteosarcoma was delayed by more than 100 days, and
that delay persisted for all of the tumours that appeared, i.e. for the entire
lifespan of the mice (P=0.005). This lifetime protection was also apparent
R. E. J. Mitchel
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FIGURE 6. The appearance of lymphomas in unexposed or radiation exposed genetically normal
(Trp53 +/+) or cancer prone (Trp53 +/-) mice.
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for the spontaneous lymphomas shown in Figure 6. However, unlike the
case for spontaneous lymphomas (Figure 6), increasing the low dose to
100 mGy resulted in a general acceleration of the appearance of the spon-
taneous spinal osteosarcomas (P<0.04, Figure 7). This decrease in cancer
latency clearly represents an increase in risk, rather than the risk decrease
seen at 10 mGy. For this tissue type therefore, the upper threshold for
protective effects of a low dose must lie between 10 and 100 mGy. Since,
in the same animals, the upper dose threshold for protection against lym-
phomas exceeded 100 mGy, we conclude that the dose threshold, where
protective effects give way to detrimental effects, is tissue-type specific. 
III. CONCLUSIONS
This paper has described experimental tests, at the molecular, cellu-
lar and whole animal levels, of the validity of the Linear No-Threshold
Hypothesis at low doses and dose rates. Using a variety of endpoints, some
surrogate for risk estimates and others direct measures of cancer risk in
vivo, the hypothesis has failed at all levels. The LNT hypothesis states that
risk per unit dose is constant without a threshold; i.e. that risk is additive
and can only increase. The results in cells and in vivo show that risk
decreases, rather than increases with increasing dose. This reduction in
risk below the spontaneous risk level is also not linear with dose. The
decrease appears to reach a maximum with the first track of radiation
through the cells, i.e. at the lowest dose physically possible in a cell, and
stays at that level until the dose reaches about 100 mGy where risk then
rises above the spontaneous level. These results indicate that at low dose
rate, the assumption of linearity may be valid only at doses above about
100 mGy (with some variation in different tissue types), and below this
Low doses of radiation reduce risk in vivo
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FIGURE 7. The appearance of spontaneous osteosarcomas in unexposed cancer prone mice (Trp53
+/-), or exposed to 10 or 100 mGy at low dose rate. Exposure to 4 Gy is shown for comparison.
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level radiation-induced protective effects dominate risk. The results in
human and other mammalian cells, and in whole animals, described here
parallel earlier observations in lower organisms, indicating that these
adaptive responses to low doses are not unique to mammals but are part
of an evolutionarily conserved response. These protective responses
appear to dominate even in individuals that are radiation sensitive and
cancer prone for genetic reasons. 
Since radiation exposures in the nuclear industry are overwhelming-
ly in this low dose and low dose rate region, these results should be con-
sidered for their implications for radiation protection and industry prac-
tices. In particular, the use of the LNT hypothesis for risk estimation at
low doses should be reviewed.
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